PNC-27 30mg — Vial Spec, Reconstitution Math & COA

Overview of PNC-27 30mg Mass and Target Research Applications

The 30mg vial configuration of PNC-27 is designed primarily for institutional research facilities, academic laboratories, and high-throughput screening environments that require concentrated stock solutions or repeated multi-well assay treatments. Containing 30 milligrams of pure, lyophilized PNC-27 peptide, this format allows investigators to minimize vial turnover, standardize baseline concentrations across large experimental sets, and reduce plastic waste in high-volume cell culture workflows.

PNC-27 is a synthesized research peptide derived from a specific membrane-interacting domain attached to a cell-penetrating peptide sequence. In preclinical models, PNC-27 is studied for its unique ability to selectively interact with transformed cell membranes. Investigators acquiring the 30mg mass specification typically run parallel assay series, comparative cytotoxicity panels, or structural biophysics studies where consistent chemical activity across hundreds of microplate wells is strictly necessary.

PNC-27 30mg Availability and PX1 Sourcing Directives

To maintain optimal peptide stability and minimize storage degradation, PX1 Research evaluates customer demand for non-standard or high-mass vial sizes. While standard catalog offerings for PNC-27 may default to lower mass increments such as 5mg or 10mg vials, custom bulk fills and 30mg unit configurations are processed for specialized laboratory requirements.

Researchers seeking immediate access to standard stock should consult our dedicated PNC-27 product page or explore our full catalog of all peptides for available formats. For laboratories requiring custom fill sizes, standardized 30mg batching, or institutional volume procurement, contact our specialized account team through the wholesale portal to request custom packaging, specific vial configurations, or lot-reserved inventory.

Reconstitution Mathematics for 30mg Lyophilized Vials

Reconstituting a 30mg lyophilized peptide cake requires careful volume calculation to achieve the target micromolar (µM) or milligram-per-milliliter (mg/mL) concentration necessary for in vitro research. Because 30mg represents a substantial mass, researchers must select diluent volumes that balance target concentration with the solubility limits of the compound.

When dissolving 30mg of PNC-27 in standard bacteriostatic water or sterile laboratory-grade solvent, the following concentration outcomes apply based on added diluent volume:

1.0 mL Diluent: Yields a concentration of 30.0 mg/mL (3.0% w/v solution). This high-density concentrate is suitable for preparing master stock solutions intended for subsequent serial dilutions in culture media.

2.0 mL Diluent: Yields a concentration of 15.0 mg/mL. This concentration balances viscosity and volumetric measurement accuracy when pipetting small working aliquots.

3.0 mL Diluent: Yields a concentration of 10.0 mg/mL. An ideal concentration for direct volumetric dilution into 96-well or 384-well assay plates requiring mid-range microgram dosing.

Investigators are encouraged to utilize our interactive reconstitution calculator to compute precise working concentrations, account for displacement volume, and convert mass units into exact assay-well molarities.

Molecular Mechanism: HDM-2 Binding and Non-p53 Necrosis

PNC-27 is classified as a membrane-active anticancer peptide investigated for its capability to target cancer cells through a p53-independent pathway. In vitro data indicate that the peptide contains a sequence corresponding to residues 12-26 of the p53 protein, bound to a transmembrane-penetrating leader peptide (penetratin). This structural conformation allows PNC-27 to target HDM-2 (human double minute 2) protein expressed specifically on the cell membrane of transformed cells.

Preclinical studies suggest that HDM-2 is selectively expressed in the outer cell membranes of various cancer cell lines, whereas non-transformed, healthy cells do not express membrane-bound HDM-2. When PNC-27 binds to membrane-bound HDM-2, it undergoes a conformational change that induces transmembrane pore formation. This pore formation leads to rapid membrane lysis and cell death via necrosis rather than apoptosis. Because this mechanism operates strictly at the cell membrane surface, the necrotic effect occurs independently of intracellular p53 signaling status, making PNC-27 a subject of high interest in p53-mutated or p53-deficient tumor cell line research.

Aliquot Planning and Preventing Freeze-Thaw Degradation

Working with a 30mg vial configuration introduces specific handling considerations regarding peptide stability. Repeatedly opening, pipetting from, or freeze-thawing a single high-mass solution compromises peptide integrity over time via hydrolysis, aggregation, and oxidation.

To preserve maximum bioactivity across long-term experimental schedules, laboratories should implement an immediate aliquoting protocol upon initial reconstitution:

Step 1: Reconstitute the 30mg cake using sterile, filtered diluent under a certified laminar flow hood.

Step 2: Gently swirl the vial until the cake is completely dissolved. Avoid aggressive vortexing, which can introduce shear stress and induce protein denaturation.

Step 3: Divide the stock solution into single-use micro-aliquots (e.g., 50 µL to 100 µL) in sterile, low-binding polypropylene microcentrifuge tubes.

Step 4: Flash-freeze the working aliquots in liquid nitrogen or an ultra-low temperature freezer (-80°C) for storage. Thaw individual aliquots immediately prior to dosing culture media, discarding any unused portion after the experimental session.

Analytical Verification: HPLC, Mass Spectrometry, and Endotoxin Testing

Precision in preclinical research requires absolute chemical verification. PX1 Research subjects every batch of synthetic peptides to rigorous analytical testing in an ISO 17025 accredited laboratory to verify sequence identity, purity, and safety profile.

High-Performance Liquid Chromatography (HPLC) is conducted to ensure that the chemical purity of PNC-27 meets or exceeds our stringent 98% purity standard. Chromatographic peaks confirm the absence of truncated sequences, residual protecting groups, or synthesis byproducts.

Mass Spectrometry (MS) confirms the exact molecular weight of the 30mg lot, ensuring structural concordance with the theoretical mass of the PNC-27 peptide sequence. Furthermore, because cell culture models are highly sensitive to bacterial contaminants, every lot undergoes chromogenic LAL testing to ensure endotoxin levels remain strictly below standard experimental thresholds (<0.01 EU/mg). Researchers can verify batch compliance by viewing our published lot reports on the COA verification page.

Thermal Stability and Storage Guidelines for Laboratory Research

Proper storage conditions are vital to maintain the structural integrity of PNC-27 before and after reconstitution. High-mass vials must be managed according to strict thermal control protocols:

Lyophilized Powder: Unopened 30mg vials should be stored at -20°C for short-to-medium term storage (up to 12 months) or -80°C for long-term storage (up to 24 months). Desiccant should be present in storage containers to protect against atmospheric humidity.

Reconstituted Solution: Once reconstituted, liquid solutions are stable at 2°C to 8°C for up to 7 days. If extended storage is required, reconstituted aliquots must be frozen at -80°C. Avoid standard frost-free freezers, as their temperature cycling accelerates peptide degradation.

For additional technical documentation regarding chemical stability and protocol optimization, explore our technical library at the PX1 Research Hub.

Comparative Analysis: PNC-27 vs. Related Research Peptides

When designing preclinical assays, investigators often evaluate PNC-27 alongside other research compounds to compare membrane dynamics, receptor affinity, or cell signaling pathways. Understanding structural and operational differences between peptide classes helps refine experimental design.

For example, while PNC-27 acts via physical pore formation upon binding membrane-bound HDM-2, signaling peptides like BPC-157 are evaluated for intracellular pathway modulation and cell migration support in tissue repair models. Similarly, growth hormone secretagogues such as CJC-1295 or GHRP-2 operate via G-protein coupled receptor (GPCR) binding to trigger downstream endocrine cascades. PNC-27 remains distinct in oncology models due to its direct, non-receptor-mediated physical disruption of cancer cell lipid bilayers.

Vial Size Selection: 30mg vs. Standard 5mg and 10mg Formats

Selecting the correct vial size depends entirely on laboratory workflow requirements, assay scale, and storage capabilities. Choosing between a high-mass 30mg format and smaller standard vials involves weighing several technical factors:

Choose 30mg Vials When: Running automated high-throughput screening, conducting large animal model trials requiring high stock volumes, or seeking to minimize lot-to-lot analytical variance across a multi-month experimental protocol.

Choose 5mg or 10mg Vials When: Conducting pilot feasibility studies, performing low-density microplate assays, or working in laboratories without ultra-low temperature (-80°C) storage where long-term storage of reconstituted aliquots is unfeasible. Smaller formats minimize product waste if an assay protocol requires fresh stock reconstitution per session.